Similarly, treatment using the USP8 inhibitor and Usp8 knockdown downregulated PD-L1 expression in pancreatic cancer cell lines, according to flow cytometry analysis (Fig. 4d, e). This evidence concerns the gene USP8 and pancreatic neoplasm.